Literature DB >> 24095850

The associations of oxidized high-density lipoprotein lipids with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.

Petri Kresanov1, Markku Ahotupa2, Tommi Vasankari3, Jari Kaikkonen4, Mika Kähönen5, Terho Lehtimäki6, Jorma Viikari7, Olli T Raitakari8.   

Abstract

Scavenging and reverse transport of atherogenic oxidized lipids by high-density lipoprotein (HDL) was recently suggested to contribute to atheroprotection. We investigated the associations of oxidized HDL lipids (oxHDLlipids) with known risk factors for atherosclerosis in a population-based cross-sectional study of 1395 Finnish adults ages 24-39 years (54.9% women). Analysis of oxidized lipids in isolated HDL and LDL (oxLDLlipids) was based on the determination of conjugated dienes. Oxidized LDL was measured also with a method based on antibodies against oxidized Apo-B (oxLDLprot). Serum lipids and risk factors were measured. In multivariable models, oxHDLlipids were associated inversely with age (partial R(2)=2.9% in men, 0.8% in women) and directly with oxLDLlipids (partial R(2)=3.4% in men, 4.2% in women) after adjustment for Apo-A1 (partial R(2)=9.6% in men, 25.2% in women). In men, oxHDLlipids were also associated inversely with insulin (partial R(2)=1.1%). In women, oxHDLlipids were additionally inversely associated with waist circumference (partial R(2)=1.8%) and daily smoking (partial R(2)=0.7%) and directly with C-reactive protein (CRP; partial R(2)=0.5%) and alcohol use (partial R(2)=0.5%). We conclude that an elevated risk profile characterized primarily by advanced age is associated with lower oxHDLlipid levels in a population of young Finnish men and women. Higher levels of oxHDLlipids are additionally associated with higher oxLDLlipid levels. In men, higher insulin levels are also associated with lower oxHDLlipid levels. In women, increased waist circumference and daily smoking are also associated with lower oxHDLlipid levels, and higher CRP levels and alcohol use are associated with higher oxHDLlipid levels.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; CVD; Free radicals; HDL; LDL; Oxidized lipids; Risk factors for atherosclerosis; cardiovascular disease; oxHDLlipids; oxLDLlipids; oxLDLprot; oxidized high-density lipoprotein lipids; oxidized low-density lipoprotein lipids; oxidized low-density lipoprotein protein

Mesh:

Substances:

Year:  2013        PMID: 24095850     DOI: 10.1016/j.freeradbiomed.2013.09.023

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  11 in total

1.  Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.

Authors:  Alexander V Sorokin; Kazuhiko Kotani; Youssef A Elnabawi; Amit K Dey; Aparna P Sajja; Shingo Yamada; Masashi Ueda; Charlotte L Harrington; Yvonne Baumer; Justin A Rodante; Joel M Gelfand; Marcus Y Chen; Aditya A Joshi; Martin P Playford; Alan T Remaley; Nehal N Mehta
Journal:  Circ Res       Date:  2018-11-09       Impact factor: 17.367

2.  Effects of a lifestyle intervention on markers of cardiometabolic risk and oxidized lipoproteins among obese adolescents with prediabetes.

Authors:  Ana Rentería-Mexía; Sonia Vega-López; Micah L Olson; Pamela D Swan; Chong D Lee; Allison N Williams; Gabriel Q Shaibi
Journal:  Public Health Nutr       Date:  2018-12-27       Impact factor: 4.022

3.  Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function.

Authors:  Quang Huy Lê; Meddy El Alaoui; Evelyne Véricel; Bérénice Ségrestin; Laurent Soulère; Michel Guichardant; Michel Lagarde; Philippe Moulin; Catherine Calzada
Journal:  J Clin Endocrinol Metab       Date:  2015-03-20       Impact factor: 5.958

4.  Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus.

Authors:  Shigeyuki Ebara; Mikio Marumo; Jun Mukai; Makoto Ohki; Kagehiro Uchida; Ichiro Wakabayashi
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

5.  Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers.

Authors:  Monica T Marin; Paul S Dasari; Jeanie B Tryggestad; Christopher E Aston; April M Teague; Kevin R Short
Journal:  J Diabetes Complications       Date:  2015-04-06       Impact factor: 3.219

6.  Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination.

Authors:  Álvaro Hernáez; María Trinidad Soria-Florido; Helmut Schröder; Emilio Ros; Xavier Pintó; Ramón Estruch; Jordi Salas-Salvadó; Dolores Corella; Fernando Arós; Lluis Serra-Majem; Miguel Ángel Martínez-González; Miquel Fiol; José Lapetra; Roberto Elosua; Rosa María Lamuela-Raventós; Montserrat Fitó
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

7.  A Randomized Controlled Trial Protocol for Using an Accelerometer-Smartphone Application Intervention to Increase Physical Activity and Improve Health among Employees in a Military Workplace.

Authors:  Emilia Pietiläinen; Heikki Kyröläinen; Tommi Vasankari; Matti Santtila; Tiina Luukkaala; Kai Parkkola
Journal:  Methods Protoc       Date:  2021-12-21

8.  Effects of Methanol Extract of Breadfruit (Artocarpus altilis) on Atherogenic Indices and Redox Status of Cellular System of Hypercholesterolemic Male Rats.

Authors:  Oluwatosin Adekunle Adaramoye; Olubukola Oyebimpe Akanni
Journal:  Adv Pharmacol Sci       Date:  2014-01-30

9.  Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis.

Authors:  Neelam Srivastava; Angelo B Cefalu; Maurizio Averna; Rai A K Srivastava
Journal:  Front Physiol       Date:  2018-09-11       Impact factor: 4.566

10.  Effects of a Two-Year Home-Based Exercise Training Program on Oxidized LDL and HDL Lipids in Coronary Artery Disease Patients with and without Type-2 Diabetes.

Authors:  Sanna Tiainen; Antti Kiviniemi; Arto Hautala; Heikki Huikuri; Olavi Ukkola; Kari Tokola; Mikko Tulppo; Tommi Vasankari
Journal:  Antioxidants (Basel)       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.